Patents

Biotechnology company files citations relevant to Benitec patent

Published in Cancer Weekly, February 8th, 2005

Nucleonics, Inc., announced that it has filed with the European Patent Office prior art citations that it believes relevant to the consideration of Benitec's patent application No. 99910039.9, entitled "Control of Gene Expression."

Nucleonics' submission provides relevant prior art documents that Benitec has not cited in its application, which show that the pending claims are invalid because they lack novelty and/or did not involve an inventive step at the time the patent application was filed. Nucleonics also believes that the claims are unclear and impermissibly extend beyond the scope of the application as filed, and that the application fails to provide adequate...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-02-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry